AIDX
20/20 Biolabs, Inc. Common Stock
NASDAQ: AIDX · HEALTHCARE · MEDICAL DEVICES
$1.49
-1.97% today
Updated 2026-05-05
Market cap
$15.62M
P/E ratio
—
P/S ratio
7.64x
EPS (TTM)
$-0.36
Dividend yield
—
52W range
$1 – $50
Volume
0.2M
20/20 Biolabs, Inc. Common Stock (AIDX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-182.80%
Operating margin
-169.60%
ROE
-503.00%
ROA
-53.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $427000.00 | $-2.23M | 40.00% | -522.44% | -521.79% |
| 2017 | $313207.00 | $-1.26M | 41.80% | -408.42% | -403.63% |
| 2018 | $277047.00 | $-1.46M | 21.46% | -532.12% | -528.11% |
| 2019 | $288300.00 | $-2.43M | 8.46% | -855.81% | -841.25% |
| 2020 | $2.33M | $-2.02M | 37.64% | -87.13% | -86.75% |
| 2021 | $9.62M | $2.07M | 48.79% | 20.18% | 21.53% |
| 2022 | $11.06M | $2.19M | 46.31% | 15.18% | 19.77% |
| 2023 | $1.42M | $-6.39M | 7.66% | -446.64% | -448.73% |
| 2024 | $1.75M | $-5.55M | 20.56% | -323.06% | -316.81% |
| 2025 | $2.05B | $-3.74B | 29.56% | -162.87% | -182.82% |